AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-82561500/cambridge-antibody-drug-royalty.html" title="Facts and information about Cambridge Antibody, Drug Royalty Announce C$126M Takeover Bid.(Brief Article)">Cambridge Antibody, Drug Royalty Announce C$126M Takeover Bid.(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.
Frequently asked questions about RSS feeds
Cambridge Antibody, Drug Royalty Announce C$126M Takeover Bid.(Brief Article)
2002 FEB 13 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CAT, CATG) a U.K.-based developer of human monoclonal antibodies as novel therapeutics and Drug Royalty Corp. (DRI), a Canada-based company whose assets primarily consist of an international portfolio of royalty interests in a variety of high profile drugs, have entered into a definitive agreement pursuant to which CAT will make an offer by way of a takeover bid for all of the issued shares of DRC.
DRC's board of directors recommends that DRC's shareholders accept CAT's offer. DRC shareholders, holding in aggregate approximately 30% of DRC's fully diluted share capital, have agreed to tender their ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Cambridge Antibody Technology ('CAT') and Drug Royalty Corporation ('DRC')...
- Press release article from: PR Newswire January 17, 2002 700+ words
...therapeutics and Drug Royalty Corporation ("DRC") , a Canada...Highlights -- DRC generates strong...its portfolio of drug royalty interests which...its portfolio of drug royalty interests and the acquisition of DRC will be of incremental...
- Drug Royalty Corporation (DRC) is Pleased to Announce That Joshua M. Salisbury...
- Press release article from: PR Newswire May 23, 2007 700+ words
TORONTO, May 23 /PRNewswire/ -- Drug Royalty Corporation Inc. (DRC) is pleased to announce that Joshua...and execution capabilities." About Drug Royalty Corporation, Inc. (DRC) Drug Royalty Corporation is a privately held investment...
- Drug Royalty Corporation (DRC) Announces Acquisition Regarding FluMist(R).
- Press release article from: PR Newswire July 9, 2007 700+ words
TORONTO, July 9 /PRNewswire/ -- Drug Royalty LP 2 (DRC) announced today it has acquired the right...About Drug Royalty Corporation, Inc. (DRC) Drug Royalty Corporation ("DRC") is a privately held investment management...
- Drug Royalty Corporation (DRC) Announces Acquisition Regarding ENBREL(R).
- Press release article from: PR Newswire May 9, 2007 700+ words
TORONTO, May 9 /PRNewswire/ -- Drug Royalty Corporation Inc. (DRC) announced today that Funds that it...over the past several years. About Drug Royalty Corporation, Inc. (DRC) Drug Royalty Corporation is a privately held investment...
- Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R)...
- Press release article from: PR Newswire August 27, 2007 700+ words
TORONTO, Aug. 27 /PRNewswire/ -- Drug Royalty LP 2 (DRC) announced today the purchase of 25% of...About Drug Royalty Corporation, Inc. (DRC) Drug Royalty Corporation ("DRC") is a privately held investment management...
- Press Release: Cambridge Antibody Technology (CAT) and Drug Royalty Corp (DRC)...
- News wire article from: Chemical Business Newsbase January 17, 2002 700+ words
...Technology (CAT) and Drug Royalty Corp (DRC) have entered into a...aggregate about 30% of DRC's fully diluted share...the offer. With this, DRC generates strong cash flow from its portfolio of drug royalty interests which CAT will...
- NPS Pharmaceuticals Announces Sale of Preotact(R) Royalty to Drug Royalty...
- Press release article from: PR Newswire July 16, 2007 700+ words
...expects to complete the drug's launch throughout the European Union this year. About Drug Royalty Corporation, Inc. (DRC) Drug Royalty Corporation ("DRC") is a privately held investment management company, focused on the healthcare industry...
- CAT outbid in acquisition of DRC, will buy back royalties.(Cambridge Antibody...
- Newspaper article from: BioWorld International Moran, Nuala March 13, 2002 700+ words
...outbid in its attempt to acquire Drug Royalty Corp., of Toronto, as a cash...royalties on its products owned by DRC. CAT made an all-share bid for DRC in January of C$126 million...terminate its royalty agreement with DRC upon payment of C$14 million...
- CAT appears out of running in bid for DRC.(Cambridge Antibody Technology Group,...
- Newspaper article from: BioWorld Week March 18, 2002 700+ words
...outbid in its attempt to acquire Drug Royalty Corp. as a cash cow, and will...royalties on its products owned by DRC. CAT, of Melbourn, UK, made...share bid for Toronto-based DRC in January of C$126 million...terminate its royalty agreement with DRC upon payment of C$14 million...
- Recommended Share Offer for Drug Royalty Corporation Inc. ('DRC') by Cambridge...
- Press release article from: PR Newswire February 4, 2002 700+ words
...CAT's offer for all of the issued shares of DRC, announced on 17 January 2002, are being posted to DRC's shareholders today. In addition to the...Listing Particulars are also being sent today to DRC's shareholders in accordance with the requirements...
Source: HighBeam Research, Cambridge Antibody, Drug Royalty Announce C$126M Takeover Bid.(Brief...